Posted on 25/06/2009 in Veterinary Supplier News Schering-Plough Animal Health is pleased it has been able to develop a preventative medication to look after the health and wellbeing of dogs.
The company has announced the first vaccine against canine influenza virus (CIV) is now available.
Because the illness is a novel pathogen, most dogs have no immunity to it.
This means there is a danger of infection spreading rapidly through pet stores, boarding kennels, animal shelters, adoption groups, veterinary clinics and other areas where the creatures congregate.
Dr Christopher Pappas is director of companion animal technical services at the company and explained the vaccine had been developed in response of the growing problem of the disease.
"We are pleased that our expertise in respiratory disease and vaccines can help prevent costly outbreaks and keep dogs healthier," he said.
Other animal products in the firm's portfolio include the swine anti-inflammatory Banamine, Estrumate for fertility disorders in cattle and Zilmax, which is used to improve production efficiencies in beef cattle.Other news stories from 25/06/2009
Read more in the Zenopa News Archive
How this news is generated
|
